Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-10-28

Clinical Trial Update: Intraocular Pressure With Loteprednol and Dexamethasone [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating intraocular pressure effects of loteprednol and dexamethasone in open-angle glaucoma and ocular hypertension; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • Loteprednol (Lotemax) (Loteprednol etabonate)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Glaucoma, Open-Angle, Ocular Hypertension | Phase 4 | Status: COMPLETED